Skip to main content

Beatriz Villafranca Magdalena

I am a PhD student in Biochemistry, Molecular Biology and Biomedicine at the Autonomous University of Barcelona. I am developing my thesis project in the group of Biomedical Research in Gynecology at Vall d´Hebron Institute de Recerca (VHIR) under the supervision of Dr. Eva Colás. My research focuses on the study of endometrial cancer, specifically, in the search of personalized treatments for the most aggressive and recurrent cases; in addition to elucidating the impact of intratumoral heterogeneity on the response to treatment.

Institutions of which they are part

Predoctoral researcher
Biomedical Research in Gynaecology
Vall Hebron Institut de Recerca

Beatriz Villafranca Magdalena

Institutions of which they are part

Predoctoral researcher
Biomedical Research in Gynaecology
Vall Hebron Institut de Recerca

I am a PhD student in Biochemistry, Molecular Biology and Biomedicine at the Autonomous University of Barcelona. I am developing my thesis project in the group of Biomedical Research in Gynecology at Vall d´Hebron Institute de Recerca (VHIR) under the supervision of Dr. Eva Colás. My research focuses on the study of endometrial cancer, specifically, in the search of personalized treatments for the most aggressive and recurrent cases; in addition to elucidating the impact of intratumoral heterogeneity on the response to treatment.

I am a proactive, self-motivated and hardworking predoctoral student in the field of biomedical research in Ginecology. I am interested in translational projects with application in clinical and pharmaceutical industries.

I have studied Biochemist and Molecular Biologist in Rovira i Virgili University (URV, Tarragona) and a MSc in Neuroscience in Barcelona University (UB). During these last
years, I have picked up the capacity to develop scientific projects in both basic and
applied biomedical research. Furthermore, I have lived both national and international experiences, which made me get robust communication skills and strong critical thinking.

During my university studies I have developed a great interest in the field of
Oncology and Ginecology through subjects like Signaling and control of cellular function and Cellular Biology. I have also gained insights in cellular and molecular biology techniques such as immunohistochemistry, western blotting and PCR by doing several internships which provided me with an overview of what research means. I am also familiarized with PDXs and I am starting now with cell cultures, specifically, organoids.

Currently, I am focused on the study of personalized treatments for the high-risk and recurrent endometrial cancers. Besides, I am also involve in a project to elucidate the impact of intratumor heterogeinity in the response to treatment, and thus, in recurrent patients.

Projects

Recerca biomèdica en ginecologia

IP: Antonio Gil Moreno
Collaborators: Natalia Rodriguez Gómez - Hidalgo, Elena Suarez Salvador, Jose Luis Poza Barrasus, Vicente Bebia Conesa, Angel García Jiménez, Maria Asuncion Perez Benavente, Carina Masferrer Ferragutcasas, Eva Colas Ortega, Sabina Salicrú Riera, Anna Ruano Lopez, Fco Javier De la Torre Fdez de Vega, Montserrat Cubo Abert, Silvia Cabrera Diaz, Laura Mañalich Barrachina, Marta Rebull Santamaria, Mireia Armengol Alsina, Ana Luzarraga Aznar, Irene De la Calle Fuentes, José Luis Sánchez Iglesias, Melissa Bradbury Lobato, Beatriz Villafranca Magdalena, Melek Denizli, Paula Cabre Fernandez
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 40000
Reference: 2021 SGR 01157
Duration: 01/01/2022 - 31/12/2024

ADVANCING ON THE DEVELOPMENT OF A NON-INVASIVE TOOL TO EARLY DIAGNOSE ENDOMETRIAL CANCER

IP: Eva Colas Ortega
Collaborators: Beatriz Villafranca Magdalena, Miriam Izquierdo Sans
Funding agency: Instituto de Salud Carlos III
Funding: 119567
Reference: FI21/00271
Duration: 01/01/2022 - 31/12/2025

ADVANCING ON THE DEVELOPMENT OF A NON-INVASIVE TOOL TO EARLY DIAGNOSE ENDOMETRIAL CANCER

IP: Eva Colas Ortega
Collaborators: Carina Masferrer Ferragutcasas, Fco Javier De la Torre Fdez de Vega, Silvia Cabrera Diaz, Irene De la Calle Fuentes, Beatriz Villafranca Magdalena
Funding agency: Instituto de Salud Carlos III
Funding: 135520
Reference: PI20/00644
Duration: 01/01/2021 - 31/12/2024

Targeting the most aggressive type of endometrial carcinoma

IP: Antonio Gil Moreno
Collaborators: Carina Masferrer Ferragutcasas, Marta Rebull Santamaria, Irene De la Calle Fuentes, Beatriz Villafranca Magdalena, Melek Denizli
Funding agency: Asociación Española Contra el Cáncer
Funding: 199250
Reference: GCTRA18014MATI
Duration: 18/02/2019 - 31/10/2024

Related news

From 6th to 7th March, more than 60 European researchers have shared the advances in translational research in endometrial cancer

On January 24, a session was held to explain what these three-dimensional models are and what advantages they have, as well as to review some of their applications in research.

A team from Vall d'Hebron Research Institute (VHIR) and the Autonomous University of Barcelona (UAB) highlights the ERK5 protein as a key factor in the resistance to cancer drugs.

Related professionals

Jorge Pamias Romero

Jorge Pamias Romero

New Technologies and Craniofacial Microsurgery
Read more
Luis Enrique Lara Moctezuma

Luis Enrique Lara Moctezuma

Kidney Physiopathology
Read more
Jorge Leno Colorado

Jorge Leno Colorado

Research technician
Genetics Medicine
Read more
José Manuel Vidal Taboada

José Manuel Vidal Taboada

Main researcher
Peripheral Nervous System
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.